![]() Additional controller (i.e., long acting beta2-agonist, long acting muscarinic antagonist, leukotriene modifier, or sustained-release theophylline) and.Medium-to-high-dose inhaled corticosteroid and. ![]() Member has inadequate asthma control despite current treatment with both of the following medications at optimized doses: Poor symptom control (frequent symptoms or reliever use, activity limited by asthma, night waking due to asthma) and.One or more asthma exacerbation resulting in hospitalization or emergency medical care visit or.Two or more asthma exacerbations requiring oral or injectable corticosteroid treatment or.Member has uncontrolled asthma as demonstrated by experiencing at least one of the following within the past year:.Member has a pre-treatment IgE level greater than or equal to 30 IU/mL and.Member has a positive skin test or in vitro reactivity to at least one perennial aeroallergen and.For treatment of moderate-to-severe asthma when all of the following criteria are met:. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |